ClinConnect ClinConnect Logo
Search / Trial NCT06780176

A Study of Breast Cancer Risk Factors and Outcomes of People in Florida

Launched by MEMORIAL SLOAN KETTERING CANCER CENTER · Jan 16, 2025

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Breast Cancer Breast Neoplasms Breast Diseases Birads Memorial Sloan Kettering Cancer Center 24 372

ClinConnect Summary

This clinical trial is focused on understanding why some people are more likely to develop breast cancer than others and how different factors may affect their outcomes. Researchers are looking at various risk factors and the results of people with breast cancer and those without it. The study is currently recruiting participants, and anyone aged 18 and older who has been seen at specific breast radiology clinics in Florida may be invited to join.

To participate, you should be someone who has had a breast exam and may need a biopsy, as identified by your healthcare provider. Anyone under 18 years old or unable to complete a survey for the study will not be eligible. If you decide to take part, you can expect to complete a survey that helps researchers gather important information about your health and experiences related to breast cancer. This study aims to improve our understanding of breast cancer risk and outcomes, which could help in developing better prevention and treatment strategies in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients with BIRADS 0-5, seen in breast radiology clinic at University of Miami (UM), Sylvester Comprehensive Cancer Center (SCCC), Jackson Health Systems (JHS) for biopsy.
  • Any new breast patient seen at UM/SCCC or JHS will be invited to participate in the study.
  • Men and women 18 years of age and older are eligible to participate in the study.
  • Exclusion Criteria:
  • Patients who are less than 18 years of age will be considered ineligible.
  • Patients unable to complete the survey.

About Memorial Sloan Kettering Cancer Center

Memorial Sloan Kettering Cancer Center (MSKCC) is a world-renowned institution dedicated to cancer treatment, research, and education. As a leading clinical trial sponsor, MSKCC focuses on advancing innovative cancer therapies through rigorous scientific investigation and collaboration. The center's multidisciplinary team of experts employs cutting-edge methodologies to design and conduct trials that aim to improve patient outcomes and enhance understanding of cancer biology. With a commitment to translating research findings into clinical practice, MSKCC plays a pivotal role in shaping the future of oncology care and ensuring that patients have access to the latest therapeutic advancements.

Locations

Miami, Florida, United States

New York, New York, United States

Los Angeles, California, United States

Patients applied

0 patients applied

Trial Officials

Neha Goel, MD, MPH

Principal Investigator

Memorial Sloan Kettering Cancer Center

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported